FRANKFURT, Feb 19 (Reuters) - The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose injection pen, according to a meeting agenda posted on the watchdog's website on Monday. (Reporting by Ludwig Burger Editing by David Goodman )